Observed Complications from Dexamethasone Intravitreal Implant for the Treatment of Macular Edema in Retinal Vein Occlusion over 3 Treatment Rounds

Retina

Volumn 35, Issue 8, 2015, Pages 1647-1655

  Reid, Gerard A ^a   Sahota, Dilraj S ^a   Sarhan, Mahmoud ^a  

^a CALDERDALE ROYAL HOSPITAL   (United Kingdom)

Author keywords

adverse effects; dexamethasone; intavitreal implant; macular edema; retinal vein occlusion

Indexed keywords

DEXAMETHASONE; ANTIHYPERTENSIVE AGENT; DRUG IMPLANT; GLUCOCORTICOID;

BRANCH RETINAL VEIN OCCLUSION; CATARACT; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; EDEMA; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE ABNORMALITY; INTRAVITREAL IMPLANT; MACULAR EDEMA; MAJOR CLINICAL STUDY; RETINA VEIN OCCLUSION; REVIEW; TREATMENT OUTCOME; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG IMPLANT; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; OCULAR HYPERTENSION; OCULOPLETHYSMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VISUAL ACUITY;

ANTIHYPERTENSIVE AGENTS; CATARACT; CATARACT EXTRACTION; DEXAMETHASONE; DRUG IMPLANTS; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; OCULAR HYPERTENSION; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR; VISUAL ACUITY;

EID: 84938800270     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000524     Document Type: Review

References (23)

1. Yau J, Lee P, Wong T, Best J. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 2008;38:904-910.
2. Glanville J, Patterson J, McCool R, et al. Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review. BMC Ophthalmol 2014;14:7.
3. Shyangdan D, Cummins E, Lois N, Royle P. Evidence review: dexamethasone implants (Ozurdex) for macular oedema after retinal vein occlusion. Single technology appraisal (STA) AbHTAG. 2010. Available at: http://www.nice.org.uk/nicemedia/live/13037/52883/52883.pdf. Accessed July 2014.
4. Haller JA, Bandello F, Belfort R Jr., et al. Randomized, sham-controlled Trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.e3.
5. National Institute for Health and Care Excellence. Dexameth-asone Intravitreal Implant for the Treatment of Macular Oedema Secondary to Retinal Vein Occlusion. [TA229]. London, England: National Institute for Health and Care Excellence; 2011. Available at: http://www.nice.org.uk/nicemedia/live/13541/55590/55590.pdf. Accessed July 2014.
6. Haller JA, Bandello F, Belfort R Jr., et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453-2460.
7. McLean JM, Woods AC. Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Trans Am Ophthalmol Soc 1950;48:293-294.
8. Jones R, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 2006;17:163-167.
9. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403-420.
10. Jonas JB, Kreissig I, Degenring RF. Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye (Lond) 2004;18:361-364.
11. Pommier S, Meyer F. RE-MI-DO Study: results of a multi-center study of dexamethasone implantation in eyes with macular oedema in retinal vein occlusion. Acta Ophthalmol 2012;90:1755-3768.
12. Moisseiev E, Goldstein M, Waisbourd M, et al. Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion. Eye (Lond) 2013;27:65-71.
13. Joshi L, Yaganti S, Gemenetzi M, et al. Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed. Br J Ophthalmol 2013;97: 1040-1044.
14. Querques L, Querques G, Lattanzio R, et al. Repeated intra-vitreal dexamethasone implant (Ozurdex) for retinal vein occlusion. Ophthalmologica 2013;229:21-25.
15. Coscas G, Augustin A, Bandello F, et al. Retreatment with ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2014;24:1-9.
16. Capone A Jr., Singer MA, Dodwell DG, et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta Study). Retina 2014;34:342-351.
17. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Oph-thalmol 2004;138:740-743.
18. Frucht J, Shapiro A, Merin S. Intraocular pressure in retinal vein occlusion. Br J Ophthalmol 1984;68:26-28.
19. Lindblom B. Open angle glaucoma and non-central retinal vein occlusion-the chicken or the egg? Acta Ophthalmol Scand 1998;76:329-333.
20. Hayreh SS, Zimmerman MB, Beri M, et al. Intraocular pressure abnormalities associated with central and hemi-central retinal vein occlusion. Ophthalmology 2004;111: 133-141.
21. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005;24: 493-519.
22. Jonas JB. Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res 2006;38:218-245.
23. Petersen A, Carlsson T, Karlsson J-O, et al. Effects of dexa-methasone on human lens epithelial cells in culture. Mol Vis 2008;14:1344-1352.